0.08Open0.08Pre Close0 Volume5 Open Interest67.00Strike Price0.00Turnover71.89%IV12.42%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type-0.0348Delta0.0136Gamma955.13Leverage Ratio-0.0471Theta-0.0003Rho-33.19Eff Leverage0.0061Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet